Posts by Follicle Thought
RiverTown Therapeutics Inc. Clinical Update
I’ve had many readers inquire lately about the current progress of RiverTown Therapeutics Inc.’s RT1640. RTI’s therapy for hair regeneration, RT1640, is a topical medication composed of minoxidil, cyclosporine A, and a novel molecule called RT175. The company debuted some impressive hair growth photos on this site last year. The question that’s been on a…
Read MoreAsia: Hair Growth R&D
Just when we thought we knew of every company in the world working on hair growth treatments… With all of the scientific articles on hair biology that continually get published from Asian establishments there was bound to be a few companies springing up at some point. I’m happy to say I’ve got 4 new companies…
Read MoreHairClone Cont., KROX20 Discovery: Weekly Thoughts 5/23/17
Hello Everyone, Welcome to a new edition of Weekly Thoughts. I’ve got some details to share on how things are going at HairClone these days, as well as notions on two promising studies on genes involved in hair growth. One of the studies has had the internet ablaze lately with KROX talk. It’s surely a…
Read MoreFollicum Phase 1/2A Hair Growth Results
Two days ago, I received an email from one of my readers which informed me that Follicum had just made an announcement about important developments that would be of interest to me. Upon further investigation, I found the Follicum website (only on the “Swedish” content) had put out a press release pertaining to the results…
Read MoreAnti-Aging Peptide, Replicel Check-In: Weekly Thoughts 4/7/17
Hello Everyone, It is good to be back for another Weekly Thoughts. This edition is headlined by an anti-aging technology from The Netherlands that has shown interesting regenerative effects on mice. I even got some exclusive info on the potential of this technology to be applied to hair growth to share with you. Also, we…
Read MoreHairClone in Action, Scar Prevention: Weekly Thoughts 2/4/17
Hello everyone, Welcome to another edition of Weekly Thoughts. I’ve been looking for some significant info to share with you all and today I came across just that. I expect this news to create quite a positive ripple in the hair enthusiast crowd. Let’s see what’s going on. HairClone Begins Dr. Bessam Farjo tweeted this…
Read More2017: A Look Ahead
I’ve got a good feeling about 2017… For the past several years we have been pacified by the news of a research study or startup company working on a treatment that grows hair. Ultimately, we would prefer the treatment in our hands, but reading about it on a computer screen has been supportive as well.…
Read MoreKelopesia Update, Brotzu Trial, Cures: Weekly Thoughts 12/16/16
Hey everybody, welcome to another edition of Weekly Thoughts. This week I touch on two topicals that have been at the forefront of hair growth enthusiasts’ attention this past year. Also, I take a look at an intriguing healthcare legislation that was just passed this week in the United States. Kelopesia Update Remember when Kelopesia…
Read MoreRiverTown Therapeutics Inc. Launches Website
Today, I woke up to discover that one of my favorite companies developing a hair growth treatment, RiverTown Therapeutics Inc., has launched their website. Site can be viewed here. One of the new significant announcements shared on the website is the introduction of the Scientific Advisory Board which includes two familiar names: Maria Hordinsky MD…
Read More2016: A Year in Review
It does not feel that long ago that I wrote the article 2016: A Look Ahead, but just like that here I am bringing a recap of a rather exciting year in the hair growth industry. To start, let’s review what I highlighted in the original “2016 look ahead” post. Samumed’s Phase II results –…
Read More